Lex genetica: the law and ethics of programming biological code

Area of Science:

• Biotechnology
• Genetic Engineering
• Bioethics

Background:

• Advances in genetic engineering enable the creation of programmable biological artifacts.
• These artifacts can incorporate usage constraints, impacting ownership and control of biotechnology products.
• Existing analyses of digital content management offer insights but do not fully address unique challenges in biological programming.

Purpose of the Study:

• To evaluate the legal and ethical implications of programmable biological artifacts.
• To analyze the interplay between law and embedded technological values in biotechnology.
• To re-examine disclosure and consent principles in light of embedded contractual terms in biological artifacts.

Main Methods:

• Comparative analysis of legal frameworks for digital content and biological artifacts.
• Conceptual evaluation of technologically embedded values in biotechnology.
• Examination of existing legal doctrines on disclosure and consent.

Main Results:

• Programmable biological artifacts introduce novel legal and ethical challenges beyond digital content.
• Embedded contractual terms in biological artifacts necessitate a re-evaluation of traditional legal concepts.
• The balance of ownership and control is significantly altered by biological programming.

Conclusions:

• Current legal frameworks require adaptation to address programmable biological artifacts.
• New approaches to disclosure and consent are essential for biotechnology transactions.
• Understanding the intersection of law and embedded values is critical for responsible innovation.